ArticleFrontiers in sleep2025

Concentrated micro choice-based treatment for type 2 diabetes is associated with decreased risk of sleep apnoea, less daytime sleepiness and lower insomnia symptoms. A non-randomized pre - post pilot study.

Ane Wilhelmsen-Langeland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.